Sp72

WELCOME & INTRODUCTIONS

Date
May 6, 2023
Explore related products in the following collection:

Society: ASGE

Presenters

Speaker Image for Mohamed Othman
Baylor College of Medicine
Speaker Image for Harish Gagneja
Austin Gastroenterology

Tracks

Related Products

Thumbnail for CLINICAL OUTCOMES OF PERORAL ENDOSCOPIC MYOTOMY (POEM) IN PATIENTS WITH SPASTIC ESOPHAGEAL MOTILITY DISORDERS ON CHRONIC OPIOID USE: A MULTICENTER STUDY
CLINICAL OUTCOMES OF PERORAL ENDOSCOPIC MYOTOMY (POEM) IN PATIENTS WITH SPASTIC ESOPHAGEAL MOTILITY DISORDERS ON CHRONIC OPIOID USE: A MULTICENTER STUDY
BACKGROUND: Video analysis has emerged as a potentially strategy for performance assessment of specialized techniques where local expertise and mentorship are limited…
Thumbnail for ASGE Innovations to Improve Endoscopic Practice
Thumbnail for MULTICENTER STUDY EVALUATING LEARNING CURVES AND COMPETENCE IN COLORECTAL ENDOSCOPIC MUCOSAL RESECTION (C-EMR) AMONG ADVANCED ENDOSCOPY TRAINEES USING AN EMR STANDARDIZED ASSESSMENT TOOL (EMR-STAT): INTERIM ANALYSIS
MULTICENTER STUDY EVALUATING LEARNING CURVES AND COMPETENCE IN COLORECTAL ENDOSCOPIC MUCOSAL RESECTION (C-EMR) AMONG ADVANCED ENDOSCOPY TRAINEES USING AN EMR STANDARDIZED ASSESSMENT TOOL (EMR-STAT): INTERIM ANALYSIS
Training in interventional endoscopy is offered by interventional endoscopy fellowship programs (IEFPs) not accredited by the ACGME. The number of these programs has increased exponentially with a concurrent increase in the breadth and complexity of these procedures…
Thumbnail for ENDOSCOPIC SUBMUCOSAL DISSECTION OF ESOPHAGEAL ADENOCARCINOMA DEEMED PATHOLOGICALLY CURATIVE RESULTS IN FEW RECURRENCES AT LONG-TERM SURVEILLANCE: A NORTH AMERICAN STUDY
ENDOSCOPIC SUBMUCOSAL DISSECTION OF ESOPHAGEAL ADENOCARCINOMA DEEMED PATHOLOGICALLY CURATIVE RESULTS IN FEW RECURRENCES AT LONG-TERM SURVEILLANCE: A NORTH AMERICAN STUDY
Current guidelines advise esophagectomy for submucosal esophageal adenocarcinoma (T1b EAC). However, data from retrospective studies suggest that endoscopic follow-up (FU) may be a valid alternative in patients without signs of lymph node metastases (LNM) at baseline…